atropine has been researched along with orphenadrine in 23 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (orphenadrine) | Trials (orphenadrine) | Recent Studies (post-2010) (orphenadrine) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 541 | 61 | 59 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (73.91) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 3 (13.04) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Mendelson, G | 1 |
| Bowers, MB; Roth, RH | 1 |
| Berry, WK; Davies, DR; Gordon, JJ | 1 |
| Brocklehurst, JC; Killane, JB | 1 |
| Brocklehurst, JC; Dillane, JB | 1 |
| Costall, B; Naylor, RJ | 1 |
| Florio, V; Longo, VG | 1 |
| Ban, T; Hojo, M | 1 |
| Boman, K; Meurman, T | 1 |
| Schnieden, H; Truslove, GM | 1 |
| Collins, AJ; Horlington, M | 1 |
| Camarasa, J; Camins, A; Canudas, AM; Escubedo, E; Pallàs, M; Pubill, D; Sureda, FX | 1 |
| GOLDSTEIN, L; JENNEY, EH; MURPHREE, HB; PFEIFFER, CC | 1 |
| DRAPER, IT; JOHNS, RJ | 1 |
| BOISSIER, JR; SIMON, P | 1 |
| BOSKOVIC, B; CATOVIC, S; STERN, P | 1 |
| HERZ, A; HOFSTETTER, A; KURZ, H; TESCHEMACHER, H | 1 |
1 review(s) available for atropine and orphenadrine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
22 other study(ies) available for atropine and orphenadrine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Letter: Hallucinogenic plants.
Topics: Acridines; Atropine; Hallucinations; Humans; Orphenadrine; Plant Poisoning; Psychoses, Substance-Induced; Tacrine | 1975 |
Interaction of atropine-like drugs with dopamine-containing neurones in rat brain.
Topics: Animals; Atropine; Benztropine; Brain; Chlorpromazine; Dopamine; Homovanillic Acid; Male; Methyltyrosines; Neurons; Orphenadrine; Phenothiazines; Procyclidine; Rats; Time Factors; Trihexyphenidyl | 1972 |
Protection of animals against soman (1,2,2-trimethylpropyl methylphosphono-fluoridate) by pretreatment with some other organophosphorus compounds, followed by oxime and atropine.
Topics: Amitriptyline; Animals; Atropine; Bromides; Carbamates; Cholinesterase Inhibitors; Diphosphates; Drug Antagonism; Female; Fluorine; Guinea Pigs; Hydroxamic Acids; Isoflurophate; Lethal Dose 50; Nitrates; Nitrophenols; Nitroso Compounds; Organophosphonates; Organophosphorus Compounds; Orphenadrine; Oximes; Parasympatholytics; Physostigmine; Poisoning; Pyridinium Compounds; Rabbits; Rats; Salicylates; Scopolamine; Species Specificity; Sulfonic Acids; Sulfuric Acids; Thiazoles; Time Factors | 1971 |
Studies of the female bladder in old age. IV. Drug effects in urinary incontinence.
Topics: Aged; Atropine; Ephedrine; Female; Humans; Indenes; Manometry; Muscles; Orphenadrine; Pempidine; Pentolinium Tartrate; Quaternary Ammonium Compounds; Urinary Incontinence | 1967 |
Studies of the female bladder in old age. IV. Drug effects in urinary incontinence.
Topics: Aged; Atropine; Ephedrine; Female; Humans; Indenes; Manometry; Muscles; Orphenadrine; Pempidine; Pentolinium Tartrate; Quaternary Ammonium Compounds; Urinary Incontinence | 1967 |
Modification of amphetamine effects by intracerebrally administered anticholinergic agents.
Topics: Animals; Atropine; Behavior, Animal; Corpus Striatum; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Ethylamines; Globus Pallidus; Humans; Injections; Injections, Intraperitoneal; Male; Motor Activity; Orphenadrine; Parasympatholytics; Pyridones; Rats; Stereotyped Behavior; Time Factors | 1972 |
Effects of amantadine and of some synthetic antiparkinsonian drugs on the behavioral response to L-DOPA in mice.
Topics: Amantadine; Amitriptyline; Animals; Antiparkinson Agents; Atropine; Behavior, Animal; Dihydroxyphenylalanine; Diphenhydramine; Drug Synergism; Imipramine; Mice; Orphenadrine; Parasympatholytics; Pargyline; Trihexyphenidyl | 1971 |
Comparison of the electroencephalographic and motor effects of orphenadrine, an antiparkinson agent.
Topics: Animals; Arousal; Atropine; Brain; Chlorpromazine; Depression, Chemical; Electric Stimulation; Electroencephalography; Injections, Intravenous; Male; Mephenesin; Motor Activity; Orphenadrine; Pentobarbital; Rabbits; Scopolamine; Stimulation, Chemical; Tectum Mesencephali | 1968 |
Investigations on the effect of some drugs on the Parkinsonian rigidity.
Topics: Adult; Atropine; Biperiden; Female; Humans; Injections, Intravenous; Male; Middle Aged; Muscle Contraction; Orphenadrine; Oscillometry; Parasympatholytics; Parkinson Disease; Procyclidine; Tropanes | 1970 |
The effect of some drugs on genetic tremor in the mouse.
Topics: Acetylcholine; Age Factors; Animals; Atropine; Barbiturates; Behavior, Animal; Body Weight; Brain; Brain Chemistry; Dopamine; Female; Genetics; Histocytochemistry; Male; Methyldopa; Mice; Norepinephrine; Orphenadrine; Scopolamine; Serotonin; Tremor | 1970 |
A sequential screning test based on the running component of audiogenic seizures in mice, including reference compound PD50 values.
Topics: Acetazolamide; Animals; Anticonvulsants; Atropine; Chloral Hydrate; Chlordiazepoxide; Ethosuximide; Haloperidol; Hydroxybutyrates; Hypnotics and Sedatives; Meprobamate; Methods; Mice; Motor Activity; Orphenadrine; Phenobarbital; Phenytoin; Primidone; Sound | 1969 |
Antiparkinsonism drugs.
Topics: Antidepressive Agents; Atropine; Diphenhydramine; Humans; Orphenadrine; Parasympatholytics; Parkinson Disease; Promethazine; Scopolamine; Trihexyphenidyl | 1965 |
Assessment of the adrenergic effects of orphenadrine in rat vas deferens.
Topics: Adrenergic Agents; Animals; Atropine; Binding, Competitive; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Epididymis; Fluoxetine; In Vitro Techniques; Ligands; Male; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Norepinephrine; Orphenadrine; Phencyclidine; Prazosin; Rats; Rats, Sprague-Dawley; Vas Deferens | 1999 |
ELECTROENCEPHALOGRAPHIC ASSAY OF ANTI-ANXIETY DRUGS.
Topics: Adolescent; Anti-Anxiety Agents; Atropine; Chlordiazepoxide; Diphenhydramine; Electroencephalography; Meprobamate; Orphenadrine; Pharmacology; Placebos | 1964 |
THE DISORDERED MOVEMENT IN PARKINSONISM AND THE EFFECT OF DRUG TREATMENT.
Topics: Atropine; Dextroamphetamine; Diphenhydramine; Drug Therapy; Geriatrics; Humans; Kinetics; Motor Skills; Movement Disorders; Orphenadrine; Parasympatholytics; Parkinsonian Disorders; Reaction Time; Trihexyphenidyl | 1964 |
[EXPERIMENTAL ANTICATALEPTIC ACTION OF SOME ANTIPARKINSONIAN AGENTS].
Topics: Antiparkinson Agents; Atropine; Catalepsy; Nortropanes; Orphenadrine; Parasympatholytics; Pharmacology; Prochlorperazine; Rats; Research; Scopolamine; Toxicology | 1964 |
THE SITE OF ACTION OF ANTIPARKINSONISM DRUGS.
Topics: Acetylcholine; Animals; Anterior Horn Cells; Anticonvulsants; Atropine; Carbachol; Cell Biology; Heterocyclic Compounds; Mice; Orphenadrine; Research; Scopolamine; Spinal Cord; Tremor; Tubocurarine | 1964 |
THE IMPORTANCE OF LIPID-SOLUBILITY FOR THE CENTRAL ACTION OF CHOLINOLYTIC DRUGS.
Topics: Atropine; Benactyzine; Blood-Brain Barrier; Brain; Cholinergic Antagonists; Diphenhydramine; Electroencephalography; Lipids; Mice; Morphine; Orphenadrine; Parasympatholytics; Parasympathomimetics; Pharmacology; Pupil; Rabbits; Rats; Research; Scopolamine; Solubility | 1965 |